|
Platelet function inhibitors
Citations 131-140 of 251 total displayed.
|
Past content
(since Oct 2000):
|
- Articles
Abciximab-Supported Infarct Artery Stent Implantation for Acute Myocardial Infarction and Long-Term Survival. A Prospective, Multicenter, Randomized Trial Comparing Infarct Artery Stenting Plus Abciximab With Stenting Alone
- David Antoniucci, Angela Migliorini, Guido Parodi, Renato Valenti, Alfredo Rodriguez, Albrecht Hempel, Gentian Memisha, and Giovanni Maria Santoro
Circulation published April 5, 2004, doi:10.1161/01.CIR.0000126284.40075.98
[Abstract]
- Focused Perspectives
If There’s Smoke, Is There Fire?
- James J. Ferguson
Circulation 2004;109:1442-1444, doi:10.1161/01.CIR.0000121321.78634.4B
[Full text]
- Brief Rapid Communications
Clinical Pharmacology of Platelet, Monocyte, and Vascular Cyclooxygenase Inhibition by Naproxen and Low-Dose Aspirin in Healthy Subjects
- Marta L. Capone, Stefania Tacconelli, Maria G. Sciulli, Marilena Grana, Emanuela Ricciotti, Pietro Minuz, Patrizia Di Gregorio, Gabriele Merciaro, Carlo Patrono, and Paola Patrignani
Circulation 2004;109:1468-1471; published online before print as doi:10.1161/01.CIR.0000124715.27937.78
[Abstract]
[Full text]
- Clinical Investigations and Reports
Beneficial Effects of Clopidogrel Combined With Aspirin in Reducing Cerebral Emboli in Patients Undergoing Carotid Endarterectomy
- David A. Payne, Chris I. Jones, Paul D. Hayes, Matthew M. Thompson, Nicholas J. London, Peter R. Bell, Alison H. Goodall, and A. Ross Naylor
Circulation 2004;109:1476-1481; published online before print as doi:10.1161/01.CIR.0000121739.05643.E6
[Abstract]
[Full text]
- Brief Rapid Communications
Atorvastatin Does Not Affect the Antiplatelet Potency of Clopidogrel When It Is Administered Concomitantly for 5 Weeks in Patients With Acute Coronary Syndromes
- John V. Mitsios, Athanasios I. Papathanasiou, Foteini I. Rodis, Moses Elisaf, John A. Goudevenos, and Alexandros D. Tselepis
Circulation 2004;109:1335-1338; published online before print as doi:10.1161/01.CIR.0000124581.18191.15
[Abstract]
[Full text]
- Articles
Clinical Pharmacology of Platelet, Monocyte, and Vascular Cyclooxygenase Inhibition by Naproxen and Low-Dose Aspirin in Healthy Subjects
- Marta L. Capone, Stefania Tacconelli, Maria G. Sciulli, Marilena Grana, Emanuela Ricciotti, Pietro Minuz, Patrizia Di Gregorio, Gabriele Merciaro, Carlo Patrono, and Paola Patrignani
Circulation published March 22, 2004, doi:10.1161/01.CIR.0000124715.27937.78
[Abstract]
- Articles
Atorvastatin Does Not Affect the Antiplatelet Potency of Clopidogrel When It Is Administered Concomitantly for 5 Weeks in Patients With Acute Coronary Syndromes
- John V. Mitsios, Athanasios I. Papathanasiou, Foteini I. Rodis, Moses Elisaf, John A. Goudevenos, and Alexandros D. Tselepis
Circulation published March 15, 2004, doi:10.1161/01.CIR.0000124581.18191.15
[Abstract]
- Articles
Beneficial Effects of Clopidogrel Combined With Aspirin in Reducing Cerebral Emboli in Patients Undergoing Carotid Endarterectomy
- David A. Payne, Chris I. Jones, Paul D. Hayes, Matthew M. Thompson, Nicholas J. London, Peter R. Bell, Alison H. Goodall, and A. Ross Naylor
Circulation published March 8, 2004, doi:10.1161/01.CIR.0000121739.05643.E6
[Abstract]
- Focused Perspectives
Are Stenting and Glycoprotein IIb/IIIa Blockade of Good Value in Primary Percutaneous Coronary Intervention?
- Jason H. Cole and William S. Weintraub
Circulation 2003;108:2831-2833, doi:10.1161/01.CIR.0000106681.88891.F2
[Full text]
- Clinical Investigations and Reports
Cost-Effectiveness of Coronary Stenting and Abciximab for Patients With Acute Myocardial Infarction: Results From the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) Trial
- Ameet Bakhai, Gregg W. Stone, Cindy L. Grines, Sabina A. Murphy, Louise Githiora, Ronna H. Berezin, David A. Cox, Thomas Stuckey, John J. Griffin, James E. Tcheng, David J. Cohen for the CADILLAC Investigators
Circulation 2003;108:2857-2863; published online before print as doi:10.1161/01.CIR.0000103121.26241.FA
[Abstract]
[Full text]
|
|
